Frontline Plc (NYSE: FRO) has a price-to-earnings ratio that is above its average at 11.42x. The stock has a 36-month beta value of 0.31. Opinions on the stock are mixed, with 5 analysts rating it as a “buy,” 1 as “overweight,” 0 as “hold,” and 0 as “sell.”
The public float for FRO is 143.15M, and at present, short sellers hold a 5.85% of that float. On June 03, 2025, the average trading volume of FRO was 3.02M shares.
FRO) stock’s latest price update
Frontline Plc (NYSE: FRO)’s stock price has dropped by -1.43 in relation to previous closing price of 18.12. Nevertheless, the company has seen a loss of -4.75% in its stock price over the last five trading days. businesswire.com reported 2025-05-31 that SAN CARLOS, Calif.–(BUSINESS WIRE)—- $ONC #BeOne–BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (A.
FRO’s Market Performance
Frontline Plc (FRO) has seen a -4.75% fall in stock performance for the week, with a 4.26% gain in the past month and a 7.59% surge in the past quarter. The volatility ratio for the week is 4.46%, and the volatility levels for the past 30 days are at 2.90% for FRO. The simple moving average for the past 20 days is 0.10% for FRO’s stock, with a -2.36% simple moving average for the past 200 days.
Analysts’ Opinion of FRO
Many brokerage firms have already submitted their reports for FRO stocks, with Kepler repeating the rating for FRO by listing it as a “Hold.” The predicted price for FRO in the upcoming period, according to Kepler is $15.83 based on the research report published on December 12, 2024 of the previous year 2024.
BTIG Research, on the other hand, stated in their research note that they expect to see FRO reach a price target of $30. The rating they have provided for FRO stocks is “Buy” according to the report published on October 07th, 2024.
Jefferies gave a rating of “Buy” to FRO, setting the target price at $30 in the report published on March 21st of the previous year.
FRO Trading at 9.19% from the 50-Day Moving Average
After a stumble in the market that brought FRO to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -36.21% of loss for the given period.
#####
#####
Stock Fundamentals for FRO
Current profitability levels for the company are sitting at:
- 0.36 for the present operating margin
- 0.38 for the gross margin
The net margin for Frontline Plc stands at 0.24. The total capital return value is set at 0.13. Equity return is now at value 14.79, with 5.45 for asset returns.
Based on Frontline Plc (FRO), the company’s capital structure generated 0.62 points at debt to capital in total, while cash flow to debt ratio is standing at 0.2. The debt to equity ratio resting at 1.6. The interest coverage ratio of the stock is 2.44.
Currently, EBITDA for the company is 1.15 billion with net debt to EBITDA at 3.05. When we switch over and look at the enterprise to sales, we see a ratio of 3.56. The receivables turnover for the company is 14.91for trailing twelve months and the total asset turnover is 0.33. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.82.
Conclusion
To sum up, Frontline Plc (FRO) has seen a mixed performance recently. Analysts have differing views on the stock, with some seeing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
